Concepedia

Publication | Open Access

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

DOIFull Paper Access

137

Citations

16

References

2020

Year

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin, Susan Swindells, Keikawus Arastéh, Miguel Górgolas Hernández-Mora, Vadim Pokrovsky, Pierre-Marie Girard, Shinichi Oka, Jaime Andrade‐Villanueva,
JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

This combined analysis demonstrates monthly injections of CAB + RPV LA were noninferior to daily oral CAR for maintaining HIV-1 suppression.

References

YearCitations

Page 1